Navigation Links
Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
Date:4/8/2008

Wolfgang Barnikol Resigns From Executive Positions

WITTEN, Germany, April 8 /PRNewswire-FirstCall/ -- Sangui BioTech International, Inc. (OTC: SGBI), published its financial statements for its fiscal year ended June 30, 2006, on April 3, 2008. According to the report on form 10-KSB as filed with the SEC the company almost tripled its sales of cosmetics and wound management products, although from a low level. In FY 2006, Sangui yielded sales of approximately USD 137,000 and a Gross Profit of approximately USD 19,000. Due to the ongoing cost containment program operating expenses were down 25% to approximately USD 758,000. The company reports a net loss for the year of approximately USD 743,000. The resulting accumulated deficit amounts to approximately USD 21.8 million. Total shareholders' deficit as of June 30, 2006 stands at approximately USD 384,000. Net cash used in operating activities of approximately USD 283,000 was partially offset by cash inflows from financing activities in the amount of approximately USD 235,000.

According to the 10-KSB report these conditions raise substantial doubt about the Company's ability to continue as a going concern. In order for the Company to continue its operations at its existing levels, the Company will require significant additional funds. Therefore, the Company is dependent on funds raised through equity or debt offerings.

Preliminary unaudited figures for Sangui's fiscal year ended June 30, 2007, indicate that Sangui yielded sales in this period of approximately USD 373,000. An increase in operating expenses which is attributable to increased marketing and sales efforts is the main factor for the resulting net loss of approximately USD 704,000. The company strives to file its pending quarterly and annual reports for its 2007 and 2008 fiscal years over the next couple of months.

Cornerstones of Sangui's current business include sales of cosmetics and wound management products thr
'/>"/>

SOURCE Sangui BioTech International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sangui Partnership Enters a New Phase:
2. Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing
3. Amsterdam Molecular Therapeutics Part of Next Biotech Index
4. Raven biotechnologies Announces Collaboration With Monogram Biosciences to Advance Diagnostic Cancer Technologies
5. Hawaii Biotech Receives Funding From the Pediatric Dengue Vaccine Initiative
6. Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
7. EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center
8. Genetic Engineering & Biotechnology News reports on cancer biomarkers
9. Biotech Avoids Fall Out From Tough Quarter for Capital Markets
10. HighPoint Solutions Selected by Global Biotechnology Company to Provide Master Data Management Solution
11. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), a life sciences company ... for advanced microarray diagnostics, today announced it has ... Management team. In his capacity as CFO he ... a development stage to a commercially successful company ... capital market strategy and to secure funding to ...
(Date:3/3/2015)... 2015 BlueInGreen announces ... international sales network. The business venture will bring ... Canada’s Atlantic Provinces, exclusively through Resource Systems. , ... of Canada’s premiere manufacturing representative firms, hosting a ... water and wastewater markets. More information on Resource ...
(Date:3/3/2015)...  Regenicin, Inc. (OTC Bulletin Board: RGIN ... and commercialization of regenerative cell therapies to restore the ... it has received the final payment to conclude The ... Bulletin Board: AMBS ). ... payments due to Regenicin in the amount of $2.3 ...
(Date:3/3/2015)... The winners of awards for supply chain ... Global Supply Chain Resiliency Council (GSCRC) at ... February 25th, 2015, at the Hyatt Regency in Santa ... together supply chain risk management and resiliency practitioners with ... through opportunities to collaborate, develop and share best practices, ...
Breaking Biology Technology:SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3BlueInGreen® Continues Canadian Expansion, Partners with Resource Systems Inc. 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4
... Lumen ... ... ANPI , TSX: ANP) today announced that it will introduce and,exhibit ... Radiology (SIR) Annual Scientific Meeting to be,held in Washington, DC from ...
... March 13 ViroPharma Incorporated,(Nasdaq: VPHM ) ... chief operating officer of ViroPharma, will present at ... at 1:40 P.M. ET on Tuesday,March 18, 2008. ... Marriott Copley,Place., ViroPharma,s presentation will be webcast ...
... SLN) today announces a collaboration with AstraZeneca (LSE: ... novel approaches for the delivery,of siRNA molecules. The ... delivery of siRNA molecules, in particular its success,with ... using its,proprietary AtuPLEX technology. The financial details of ...
Cached Biology Technology:Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 2Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 3Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 4Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting 5Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery 2Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery 3
(Date:2/19/2015)... DUBLIN , Feb .19, 2015 Research ... announced the addition of the "Military Electro-Optical ... by Sensor Technology, by Platform - Forecast to ... The military electro-optical/infrared systems market is expected ... a CAGR of 7.71%. This report ...
(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/12/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announced today ... DISTRIBUTED METHOD AND SYSTEM TO IMPROVE COLLABORATIVE SERVICES ... NXT-ID,s position in the emerging "Internet of Things" by ... multiple devices to collaborate with one another to improve ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... foxes, a bubbling vat of chemical reactants, and complex ... similar systems: Many scenarios can play out depending on ... can,t be precisely predicted chemicals combining, genes triggering ... eaten. Predicting possible outcomes from a set of ...
... School of Basic Medical Sciences, Beijing University of ... inhibit advanced glycation end product formation, reduce their ... and memory capabilities in ovariectomized rats. The Radix ... product accumulation is associated with an antioxidative effect. ...
... clean up city parks, or scale back their driving to ... granted and ride free on the efforts of others. They ... it. Or they run their lawn sprinklers during a drought ... A new report in Psychological Science in the ...
Cached Biology News:Computer can infer rules of the forest 2Trust in leaders, sense of belonging stir people to safeguard common goods, analysis shows 2Trust in leaders, sense of belonging stir people to safeguard common goods, analysis shows 3
... a member of the caudal-related homeobox family, ... both proliferation and differentiation in intestinal epithelial ... triggering cells towards the phenotype of differentiated ... maintenance of the phenotype. Clone CDX2-88 reacts ...
... antibody detects an ~185 kDa protein, corresponding ... phosphorylated at tyrosine 1248 on SDS-PAGE immunoblots. ... adsorbed against the non-phosphorylated peptide to remove ... of the protein. In cell lines ...
... G1 cyclin required for G1-phase progression and ... cyclin D2 can phosphorylate pRB when ... Human, Mouse, and Rat. Others-not ... well suited for neutralization of cyclin D2 ...
Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Family: Other Applications: Western Blot...
Biology Products: